ChromaCode

Multiplexing the way it should be

Carlsbad, United States · Founded 2015 · $90.5M raised

Bioinformatics
Molecular Diagnostics
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$90.5M
Last Round
$38.0M Corporate RoundFeb 2023
Rounds
5

About

ChromaCode is a molecular diagnostics company that leverages patented mathematical methods and algorithmic enhancements to enrich signal processing from popular life science instrumentation. The company's High-Definition PCR (HDPCR) multiplexing platform enables transformative genomic solutions for oncology, minimal residual disease testing, and disease monitoring. ChromaCode's instrument-agnostic platform pairs proprietary innovations in chemistry and cloud-based software to deliver unprecedented multiplexing, with pedigree from Illumina, Google X, Luminex, and Caltech.

Summary

ChromaCode is a Bioinformatics company based in Carlsbad, United States, founded in 2015. It has raised $90.5M in total across 5 rounds, most recently a $38.0M Corporate Round round in Feb 2023. Investors include Adjuvant Capital and Domain Associates.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Corporate RoundCorporate RoundFeb 2023
$38.0M

Sign up to see all 5 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies